What is Harmonic Bionics?
Harmonic Bionics operates at the intersection of advanced robotics and physical medicine. By developing intelligent hardware that facilitates precise, data-driven treatment, the company addresses a critical gap in the rehabilitation market. Their technology is specifically designed to assist care providers in managing neurological and musculoskeletal conditions, moving beyond traditional therapy methods toward a more quantifiable, technology-enabled approach. Headquartered in Austin, Texas, the company leverages its strategic location to tap into a growing ecosystem of healthtech innovation, positioning itself as a key player in the future of robotic-assisted physical therapy.
How much funding has Harmonic Bionics raised?
Harmonic Bionics has raised a total of $10.2M across 3 funding rounds:
Debt
$174K
Series A
$7M
Other Financing Round
$3M
Debt (2021): $174K with participation from PPP
Series A (2021): $7M led by Big Basin Capital, DSC Investment, Smilegate Investment, KNet Investment Partners, and Bass Investment
Other Financing Round (2022): $3M supported by CUREXO
Key Investors in Harmonic Bionics
Big Basin Capital
Big Basin Capital is an investment firm that focuses on early-stage startups in Korea and the United States, viewing their investments as the beginning of a long-term entrepreneurial partnership.
KNet Investment Partners
KNET Investment Partners LLC is a venture capital firm founded in 2008, known for its team of experienced professionals with backgrounds in global finance and corporate management.
CUREXO
Curexo Inc. is a specialized developer and distributor of medical robotics, including gait rehabilitation and surgical systems, providing deep industry expertise to its portfolio companies.
What's next for Harmonic Bionics?
With the recent influx of capital, Harmonic Bionics is well-positioned to transition into a phase of rapid commercial expansion and product refinement. The strategic nature of the latest funding suggests a focus on deepening partnerships with established medical device manufacturers and expanding the clinical footprint of their robotic systems. As the company continues to iterate on its core technology, the focus will likely shift toward securing broader regulatory approvals and scaling manufacturing capabilities to meet the rising demand for high-tech rehabilitation solutions. By leveraging the expertise of its diverse investor base, Harmonic Bionics is set to solidify its market position as a leader in the evolving landscape of movement impairment treatment.
See full Harmonic Bionics company page
